Alcoholism is a difficult addiction to overcome. Alcoholics Anonymous and other similar support groups wouldn’t exist if heavy drinkers could just give up the bottle any time they wanted, like so many of them stereotypically claim. With the help of a new kind of implant, however, this might finally be possible. Unfortunately, it also comes with a rather nightmarish privacy issue.
Very few people, if any actually enjoy being watched or monitored 24/7, but that is what an alcoholic patient would be signing up for if they decided to use an implant made by University of California San Diego (UCSD) researchers. This one cubic millimeter biosensor will act as something of an ankle bracelet. Only, instead of beeping when the wearer exits a designated area, it goes nuts when it detects alcohol.
As the project’s lead researcher Drew Hall said in a press release, the whole point to the implant is to help alcoholics develop a routine that they will stick to. It would certainly be difficult to fool people into thinking that a person has given up drinking if there’s a literal tattletale inside them all the time.
“The ultimate goal of this work is to develop a routine, unobtrusive alcohol and drug monitoring device for patients in substance abuse treatment programs,” Hall said.
While it may be potentially effective, perhaps the most effective method conceived so far, it’s also incredibly intrusive. As Futurism points out, this isn’t like the breathalyzer or blood tests that addicts would often have to contend with. It’s about having a monitor inside of them that will keep watch over them at all hours of the day.
What’s more, it seems even the researchers don’t know as much about the implant as they really should. The degree of difficulty in removing the implant, for example, is still in question.


SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
Oracle Plans $45–$50 Billion Funding Push in 2026 to Expand Cloud and AI Infrastructure
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 



